Unknown

Dataset Information

Quantitative efficacy paradigms of the influenza clinical drug candidate EIDD-2801 in the ferret model.


ABSTRACT: Seasonal influenza viruses cause major morbidity and mortality worldwide, threatening in particular older adults and the immunocompromised. Two classes of influenza therapeutics dominate current disease management, but both are compromised by pre-existing or rapidly emerging viral resistance. We have recently reported a novel ribonucleoside analog clinical candidate, EIDD-2801, that combines potent antiviral efficacy in ferrets and human airway epithelium cultures with a high barrier against viral escape. In this study, we established fundamental EIDD-2801 efficacy paradigms against pandemic and seasonal influenza A virus (IAV) strains in ferrets that can be used to inform exposure targets and treatment regimens. Based on reduction of shed virus titers, alleviation of clinical signs, and l

SUBMITTER: Toots M 

PROVIDER: S-EPMC7568909 | biostudies-literature | 2020 Apr

REPOSITORIES: biostudies-literature